Shopping Cart 0
Cart Subtotal
USD 0

Wilson Therapeutics AB (WTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Wilson Therapeutics AB (Wilson Therapeutics), a subsidiary of Alexion Pharma Nordics AB, is a biopharmaceutical company that develops novel therapies for patients with rare copper-mediated disorders. The company's lead product includes WTX101 is a copper-protein-binding agent, which is used for the treatment for wilson disease. Its product provides an alternative copper-protein transport mechanism, copper-protein complexes, de-toxify free copper and biliary excretion of copper. Wilson Therapeutics' lead product is also used for the treatment of other medical conditions including amyotrophic lateral sclerosis. The company conducts clinical trials for developing the treatment of wilson disease. Wilson Therapeutics is headquartered in Stockholm, Sweden.

Wilson Therapeutics AB (WTX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Wilson Therapeutics AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deal Details 10

Asset Purchase 10

Wilson Therapeutics Acquires Decuprate from Tactic Pharma 10

Venture Financing 11

Wilson Therapeutics Raises USD 40 Million In Series B Financing 11

Licensing Agreements 13

Wilson Therapeutics Enters into Licensing Agreement with University of Michigan 13

Equity Offering 14

Wilson Therapeutics Raises USD29 Million in Private Placement of Shares 14

Wilson Therapeutics Raises USD48 Million in IPO 16

Acquisition 18

Alexion Acquires Wilson Therapeutics for USD852 Million 18

Wilson Therapeutics Acquires TTM Europe Development from Medical Need Europe for USD6.2 Million 20

Wilson Therapeutics AB-Key Competitors 21

Wilson Therapeutics AB-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Financial Announcements 23

May 16, 2018: Wilson Therapeutics: Interim report January 1-March 31, 2018 23

Feb 21, 2018: Wilson Therapeutics Year-End Report 2017 24

Nov 23, 2017: Wilson Therapeutics Interim Report January 1-September 30, 2017 25

Aug 24, 2017: Wilson Therapeutics: Interim Report January 1-June 30, 2017 26

Corporate Communications 27

Jun 01, 2018: Delisting of Wilson Therapeutics 27

May 25, 2018: Wilson Therapeutics applies for delisting 28

Nov 09, 2017: Wilson Therapeutics' Nomination Committee appointed 29

May 22, 2017: Wilson Therapeutics Strengthens its Board of Directors by the Appointments of Birgitte Volck and Bjorn Odlander 30

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31


List Of Figure

List of Figures

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Wilson Therapeutics AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Wilson Therapeutics AB, Deals By Therapy Area, 2012 to YTD 2018 8

Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Wilson Therapeutics Acquires Decuprate from Tactic Pharma 10

Wilson Therapeutics Raises USD 40 Million In Series B Financing 11

Wilson Therapeutics Enters into Licensing Agreement with University of Michigan 13

Wilson Therapeutics Raises USD29 Million in Private Placement of Shares 14

Wilson Therapeutics Raises USD48 Million in IPO 16

Alexion Acquires Wilson Therapeutics for USD852 Million 18

Wilson Therapeutics Acquires TTM Europe Development from Medical Need Europe for USD6.2 Million 20

Wilson Therapeutics AB, Key Competitors 21

Wilson Therapeutics AB, Subsidiaries 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Wilson Therapeutics AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.